The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - A preliminary study

Archives of Medical Science

Volumn 7, Issue 1, 2011, Pages 73-80

  Budzyński, Jacek ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Dr Jan Biziel University Hospital No 2   (Poland)

Author keywords

Angina pectoris; Chest pain; Eradication therapy; Helicobacter pylori

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANTIBIOTIC THERAPY; ARTICLE; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; THORAX PAIN; TREATMENT FAILURE; UNSTABLE ANGINA PECTORIS;

EID: 79952524360     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.20607     Document Type: Article

References (39)

1. Dzieniszewski J, Jarosz M, Grupa Robocza PTG-E do spraw zakażenia Helicobacter pylori. Ustalenia Grupy Roboczej PTG-E dotycza̧ce postȩpowania w zakażeniu Helicobacter pylori - consensus 2008 [Polish]. Gastroenterol Pol 2008; 15: 323-31.
2. Budzyński J, Kłopocka M, Bujak R, Świa̧tkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 2004; 16: 451-7. (Pubitemid 38586472)
3. Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus 2009; 22: 256-63.
4. Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 2008; 86: 175-8. (Pubitemid 351301753)
5. Kłopocka M, Budzyński J, Świa̧tkowski M, Korenkiewicz L, Pulkowski G, Grad K. Influence of Helicobacter pylori infection on the results of 24-hour gastric pH-metry in patients diagnosed because of atypical chest pain. Przegl Lek 2005; 62: 843-7.
6. Budzyński J, Kłopocka M, Świa̧tkowski M, Korenkiewicz Ł, Pulkowski G, Grad K. Effect of Helicobacter pylori infection on the gastroesophageal reflux in patients with atypical chest pain. Pol Arch Med Wewn 2004; 111: 143-51.
7. Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009; 137: 1776-84.
8. Dickman R, Fass R. Noncardiac chest pain. Clin Gastroenterol Hepatol 2006; 4: 558-63.
9. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006; 18: 408-17. (Pubitemid 43742554)
10. Dickman R, Mattek N, Holub J, Peters D, Fass R. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007; 102: 1173-9. (Pubitemid 46802000)
11. Dobrzycki S, Baniukiewicz A, Korecki J, et al. Does gastroesophageal reflux provoke the myocardial ischemia in patients with CAD? Int J Cardiol 2005; 104: 67-72.
12. Budzyński J, Kłopocka M, Pulkowski G, et al. The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease - a randomised, double-blind, placebo controlled, crossover trial. Int J Cardiol 2008; 127: 233-9. (Pubitemid 351787800)
13. Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009; 202: 535-42.
14. Miyazaki M, Babazono A, Kadowaki K, Kato M, Takata T, Une H. Is Helicobacter pylori infection a risk factor for acute coronary syndromes? J Infect 2006; 52: 86-91.
15. Pellicano R, Mazzarello MG, Morelloni S, et al. Helicobacter pylori seropositivity in patients with unstable angina. J Cardiovasc Surg (Torino) 2003; 44: 605-9. (Pubitemid 38139715)
16. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083-92. (Pubitemid 41408600)
17. Montenero AS, Mollichelli N, Zumbo F. Helicobacter pylori and atrial fibrillation: a possible pathogenic link. Heart 2005; 91: 960-1. (Pubitemid 40874092)
18. Bunch TJ, Day JD, Anderson JL. Frequency of Helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. Am J Cardiol 2008; 101: 848-51.
19. Celik T, Iyisoy A, Yuksel UC. Possible pathogenetic role of Helicobacter pylori infection in cardiac syndrome X. Int J Cardiol 2010; 142: 193-4.
20. Eskandarian R, Malek M, Mousavi SH, Babaei M. Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 2006; 47: 704-6. (Pubitemid 44196859)
21. Ozdogru I, Kalay N, Dogan A, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007; 62: 501-5. (Pubitemid 47582643)
22. Saleh N, Svane B, Jensen J, Hansson LO, Nordin M, Tornvall P. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 2005; 149: 876-82. (Pubitemid 40718885)
23. Sandifer QD, Vuilo S, Crompton G. Association of Helicobacter pylori infection with coronary heart disease. Association may not be causal. BMJ 1996; 312: 251.
24. Kowalski M, Konturek PC, Pieniazek P, et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001; 33: 222-9. (Pubitemid 32452054)
25. Kowalski M, Pawlik M, Konturek JW, Konturek SJ. Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 2006; 57 (Suppl. 3): 101-11. (Pubitemid 44617514)
26. Shanker J, Kakkar VV. Role of periodontal infection in cardiovascular disease: a current perspective. Arch Med Sci 2009; 5: 125-34.
27. Ramdeen N, Aronow WS, Chugh S, Asija A. Patients undergoing coronary angiography because of chest pain with hepatitis C virus seropositivity have a higher prevalence of obstructive coronary artery disease than a control group. Arch Med Sci 2008; 4: 452-4.
28. Katoh K, Nomura M, Nakaya Y, et al. Autonomic nervous activity before and after eradication of Helicobacter pylori in patients with chronic duodenal ulcer. Aliment Pharmacol Ther 2002; 16 (Suppl. 2): 180-6. (Pubitemid 41771477)
29. Rasmi Y, Raeisi S. Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X. Cardiol J 2009; 16: 585-7.
30. Navarese EP, Franceschi F, Aurelio A, Natale L, Rebuzzi AG, Gasbarrini G. Focal myocarditis mimicking ST-elevation myocardial infarction in a patient with Helicobacter pylori infection: role of magnetic resonance with late gadolinium enhancement. Recenti Prog Med 2010; 101: 61-3.
31. Delaney BC, Hobbs FD, Holder R. Association of Helicobacter pylori infection with coronary heart disease. Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence. BMJ 1996; 312: 251-2.
32. Cheung TK, Lim PW, Wong BC. Noncardiac chest pain - an Asia-Pacific survey on the views of primary care physicians. Dig Dis Sci 2007; 52: 3043-8. (Pubitemid 47512548)
33. Mesihović R, Vucelić B, Bratović I, Gribajcević M, Selak I. Effect of eradication of Helicobacter pylori infection on endoscopic findings and symptoms of gastroesophageal reflux. Med Arh 2002; 56: 201-6.
34. Nocente R, Gentiloni N, Cremonini F, et al. Resolution of syndrome X after eradication of virulent CagA-positive Helicobacter pylori. South Med J 2000; 93: 1022-3.
35. Zaman MJ, Crook AM, Junghans C, et al. Ethnic differences in long-term improvement of angina following revascularization or medical management: a comparison between south Asians and white Europeans. J Public Health (Oxf) 2009; 31: 168-74.
36. Spencer HL, Smith L, Riley SA. A questionnaire study to assess long-term outcome in patients with abnormal esophageal manometry. Dysphagia 2006; 21: 149-55.
37. Jarosz M, Rychlik E, Siuba M, et al. Dietary and socioeconomic factors in relation to Helicobacter pylori reinfection. World J Gastroenterol 2009; 15: 1119-25.
38. Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastrooesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009; 30: 331-42.
39. Sarkar S, Thompson DG, Woolf CJ, Hobson AR, Millane T, Aziz Q. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol 2004; 99: 1998-2006. (Pubitemid 39421246)